Standout Papers
- STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD (2021)
- Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG (2006)
Immediate Impact
9 by Nobel laureates 13 from Science/Nature 99 standout
Citing Papers
Crohn's disease
2024 Standout
Ulcerative Colitis in Adults
2023 Standout
Works of Iris Dotan being referenced
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Infliximab-Related Infusion Reactions: Systematic Review
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Iris Dotan | 4830 | 4108 | 2295 | 319 | 9.2k | |
| Stephan R. Vavricka | 5204 | 4162 | 2889 | 237 | 10.6k | |
| Mark S. Silverberg | 5422 | 3703 | 2004 | 243 | 8.5k | |
| Alessandro Armuzzi | 5560 | 4219 | 3378 | 428 | 10.0k | |
| Fernando Magro | 5258 | 4076 | 2367 | 289 | 8.3k | |
| James O. Lindsay | 5244 | 3657 | 2335 | 207 | 8.9k | |
| Gordon R. Greenberg | 6689 | 5075 | 2939 | 208 | 11.7k | |
| William A. Faubion | 4006 | 3280 | 2324 | 193 | 8.7k | |
| Paul Rutgeerts | 5554 | 4024 | 3587 | 272 | 10.2k | |
| Torsten Kucharzik | 3632 | 2555 | 2446 | 194 | 9.0k | |
| Hans Herfarth | 4615 | 4079 | 2956 | 261 | 11.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...